Hubert A - Search Results

1

Liquid biopsy reveals collateral tissue damage in cancer.

Lubotzky A, Zemmour H, Neiman D, Gotkine M, Loyfer N, Piyanzin S, Ochana BL, Lehmann-Werman R, Cohen D, Moss J, Magenheim J, Loftus MF, Brais L, Ng K, Mostoslavsky R, Wolpin BM, Zick A, Maoz M, Grinshpun A, Kustanovich A, Makranz C, Cohen JE, Peretz T, Hubert A, Temper M, Salah A, Avniel-Polak S, Grozinsky-Glasberg S, Spalding KL, Rokach A, Kaplan T, Glaser B, Shemer R, Dor Y. Lubotzky A, et al. Among authors: hubert a. JCI Insight. 2022 Jan 25;7(2):e153559. doi: 10.1172/jci.insight.153559. JCI Insight. 2022. PMID: 35076021 Free PMC article.

2

Cisplatin-induced non-convulsive encephalopathy.

Lyass O, Lossos A, Hubert A, Gips M, Peretz T. Lyass O, et al. Among authors: hubert a. Anticancer Drugs. 1998 Jan;9(1):100-4. doi: 10.1097/00001813-199801000-00013. Anticancer Drugs. 1998. PMID: 9491799

3

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.

Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA. Kadouri L, et al. Among authors: hubert a. Br J Cancer. 2001 Jul 6;85(1):36-40. doi: 10.1054/bjoc.2001.1777. Br J Cancer. 2001. PMID: 11437399 Free PMC article.

4

Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapy.

Nisman B, Barak V, Hubert A, Kaduri L, Lyass O, Baras M, Peretz T. Nisman B, et al. Among authors: hubert a. Anticancer Res. 2003 Mar-Apr;23(2C):1939-42. Anticancer Res. 2003. PMID: 12820483

5

Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.

Kadouri L, Kote-Jarai Z, Easton DF, Hubert A, Hamoudi R, Glaser B, Abeliovich D, Peretz T, Eeles RA. Kadouri L, et al. Among authors: hubert a. Int J Cancer. 2004 Jan 20;108(3):399-403. doi: 10.1002/ijc.11531. Int J Cancer. 2004. PMID: 14648706 Free article.

6

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.

Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T. Kadouri L, et al. Among authors: hubert a. Br J Cancer. 2004 May 17;90(10):2002-5. doi: 10.1038/sj.bjc.6601837. Br J Cancer. 2004. PMID: 15138485 Free PMC article.

7

Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area.

Nissan A, Spira RM, Hamburger T, Badrriyah M, Prus D, Cohen T, Hubert A, Freund HR, Peretz T. Nissan A, et al. Among authors: hubert a. Am J Surg. 2004 Jul;188(1):62-7. doi: 10.1016/j.amjsurg.2003.11.039. Am J Surg. 2004. PMID: 15219486

8

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers.

Kadouri L, Kote-Jarai Z, Hubert A, Baras M, Abeliovich D, Hamburger T, Peretz T, Eeles RA. Kadouri L, et al. Among authors: hubert a. Br J Cancer. 2008 Jun 17;98(12):2006-10. doi: 10.1038/sj.bjc.6604394. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18542066 Free PMC article.

9

Vincristine-induced paralytic ileus in Parkinson's disease.

Leker RR, Peretz T, Hubert A, Lossos A. Leker RR, et al. Among authors: hubert a. Parkinsonism Relat Disord. 1997 Apr;3(2):109-10. doi: 10.1016/s1353-8020(97)00008-4. Parkinsonism Relat Disord. 1997. PMID: 18591064

10

Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.

Hubert A, Mali B, Hamburger T, Rottenberg Y, Uziely B, Peretz T, Kadouri L. Hubert A, et al. Fam Cancer. 2009;8(3):173-7. doi: 10.1007/s10689-008-9223-7. Epub 2008 Nov 19. Fam Cancer. 2009. PMID: 19016350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page